89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETNB 89Bio, Inc.

停牌 10-29 16:00:00 EDT

14.84

+0.00

0.00%

最高14.84	最低14.84	成交量0.00
今开14.84	昨收14.84	日振幅0.00%
总市值22.01亿	流通市值15.39亿	总股本1.48亿
成交额8.25亿	换手率0.00%	流通股本1.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETNB","market":"US","secType":"STK","nameCN":"89Bio, Inc.","latestPrice":14.84,"timestamp":1761768000000,"preClose":14.84,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":103725128,"shares":148308250,"eps":-3.413952,"marketStatus":"停牌","change":0,"latestTime":"10-29 16:00:00 EDT","open":14.84,"high":14.84,"low":14.84,"amount":825457336.525923,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.413952,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1778572800000},"marketStatusCode":0,"adr":0,"listingDate":1573448400000,"exchange":"NASDAQ","adjPreClose":14.84,"volumeRatio":0},"requestUrl":"/m/hq/s/ETNB","defaultTab":"news","newsList":[{"id":"1175069785","title":"罗氏收购89Bio, Inc.的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1175069785","media":"投资观察","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175069785?lang=zh_cn&edition=full","pubTime":"2025-10-30 14:18","pubTimestamp":1761805139,"startTime":"0","endTime":"0","summary":"10月30日（瑞士信贷） - 罗氏控股公司：*罗氏在89Bio, Inc.的要约收购中购买股份*罗氏控股公司 - 接受所有89Bio要约中的股份付款*罗氏控股公司 - 每股价格设定为14.50美元，加上最高6.00美元的条件价值权*罗氏控股公司 - 89Bio将成为罗氏的全资子公司*罗氏控股公司 - 约94,113,710股89Bio在要约中被提出*罗氏控股公司 - 今天稍后，罗氏计划通过与蓝鳍合并子公司的合并完成对89Bio的收购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518703262","title":"89Bio, Inc.盘中异动 股价大跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518703262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518703262?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:47","pubTimestamp":1741614433,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时47分，89Bio, Inc.股票出现波动，股价快速跳水5.10%。截至发稿，该股报7.45美元/股，成交量9.118万股，换手率0.06%，振幅3.95%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518440673","title":"89Bio, Inc.2024财年实现净利润-3.67亿美元，同比减少158.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518440673?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449623,"startTime":"0","endTime":"0","summary":"3月9日，89Bio, Inc.公布财报，公告显示公司2024财年净利润为-3.67亿美元，同比减少158.45%；其中营业收入为0.00美元，每股基本收益为-3.51美元。从资产负债表来看，89Bio, Inc.总负债77.90百万美元，其中短期债务727000.00美元，资产负债比为0.07，流动比率为0.14。机构评级：截至2025年3月9日，当前有9家机构对89Bio, Inc.目标价做出预测，其中目标均价为29.67美元，其中最低目标价为12.00美元，最高目标价为51.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516311371","title":"HC Wainwright & Co.：重申89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516311371","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516311371?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:21","pubTimestamp":1740759694,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01002148469142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514354518","title":"89bio(ETNB.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.02美元，前值为-0.50美元，预期值为-0.73美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354518","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354518?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697717,"startTime":"0","endTime":"0","summary":"89bio(ETNB.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.02美元，前值为-0.50美元，预期值为-0.73美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145283862","title":"89bio 2024年第四季度GAAP每股收益$(1.02)，低于$(0.77)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1145283862","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145283862?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:46","pubTimestamp":1740692807,"startTime":"0","endTime":"0","summary":"89bio  报告的季度亏损为每股$，低于分析师共识预期的$，低32.47%。与去年同期每股亏损$相比，减少了104%。以上内容来自Benzinga Earnings专栏，原文如下：89bio  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 32.47 percent. This is a 104 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"89bio 2024年第四季度GAAP每股收益$(1.02)，低于$(0.77)的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514389295","title":"89Bio, Inc.盘中异动 大幅上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389295?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:13","pubTimestamp":1740669233,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时13分，89Bio, Inc.股票出现异动，股价急速拉升5.21%。截至发稿，该股报9.69美元/股，成交量23.3454万股，换手率0.16%，振幅5.81%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231353a256852e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231353a256852e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514801307","title":"89Bio, Inc.盘中异动 早盘股价大跌5.03%报9.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801307?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:22","pubTimestamp":1740496952,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时22分，89Bio, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报9.62美元/股，成交量30.4897万股，换手率0.21%，振幅4.77%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232232abdc8b43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232232abdc8b43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513384720","title":"89Bio, Inc.盘中异动 早盘大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513384720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513384720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:03","pubTimestamp":1740409380,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分，89Bio, Inc.股票出现波动，股价快速跳水5.06%。截至发稿，该股报10.50美元/股，成交量11.5698万股，换手率0.08%，振幅5.47%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230300962ea0b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230300962ea0b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509280422","title":"89Bio, Inc.盘中异动 股价大涨5.40%报11.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280422?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:15","pubTimestamp":1738768527,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时15分，89Bio, Inc.股票出现波动，股价大幅上涨5.40%。截至发稿，该股报11.33美元/股，成交量46.3866万股，换手率0.32%，振幅5.35%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231528987b8407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231528987b8407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509460688","title":"89bio(ETNB.US)获Wolfe Research首次覆盖，给予优于大市评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509460688","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509460688?lang=zh_cn&edition=full","pubTime":"2025-02-05 02:19","pubTimestamp":1738693194,"startTime":"0","endTime":"0","summary":"89bio(ETNB.US)获Wolfe Research首次覆盖，给予优于大市评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05021947950297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509946570","title":"89Bio, Inc.盘中异动 股价大涨5.38%报9.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509946570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509946570?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:00","pubTimestamp":1738684807,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时00分，89Bio, Inc.股票出现异动，股价急速拉升5.38%。截至发稿，该股报9.79美元/股，成交量174.055万股，换手率1.21%，振幅3.89%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000008abc23a17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000008abc23a17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508999040","title":"瑞银：维持89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由25.00美元调整至38.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508999040","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508999040?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:21","pubTimestamp":1738351296,"startTime":"0","endTime":"0","summary":"瑞银：维持89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由25.00美元调整至38.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/01032147922801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621366","title":"89Bio, Inc.盘中异动 股价大涨5.73%报9.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621366?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247460,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分，89Bio, Inc.股票出现波动，股价快速上涨5.73%。截至发稿，该股报9.23美元/股，成交量5.3222万股，换手率0.04%，振幅0.00%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022310096143d50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022310096143d50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506148495","title":"89Bio, Inc.盘中异动 大幅上涨5.00%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506148495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506148495?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:39","pubTimestamp":1738075180,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时39分，89Bio, Inc.股票出现异动，股价急速拉升5.00%。截至发稿，该股报9.45美元/股，成交量55.2392万股，换手率0.47%，振幅4.89%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822394098756cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822394098756cab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506430510","title":"89Bio, Inc.股价拉升48.25% 市值涨6亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506430510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506430510?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988366,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，89Bio, Inc.股票出现波动，股价大幅上涨48.25%。截至发稿，该股报10.57美元/股，成交量575.264万股，换手率4.89%，振幅4.77%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223246abba5fb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223246abba5fb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489142059","title":"89Bio, Inc.盘中异动 急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489142059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489142059?lang=zh_cn&edition=full","pubTime":"2024-12-05 05:00","pubTimestamp":1733346017,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日05时00分，89Bio, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报8.29美元/股，成交量45.6699万股，换手率0.39%，振幅5.50%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205050017971bb05d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205050017971bb05d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488560860","title":"89Bio, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488560860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488560860?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:27","pubTimestamp":1733153245,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时27分，89Bio, Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报9.45美元/股，成交量5.9605万股，换手率0.05%，振幅5.12%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202232725a266b6ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202232725a266b6ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486026080","title":"89Bio, Inc.盘中异动 急速拉升5.94%报9.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486026080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486026080?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545229,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，89Bio, Inc.股票出现异动，股价急速上涨5.94%。截至发稿，该股报9.28美元/股，成交量4.4312万股，换手率0.04%，振幅2.34%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223350971a85bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223350971a85bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483306251","title":"89Bio, Inc.2024财年第三财季实现净利润-1.49亿美元，同比减少329.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306251?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686434,"startTime":"0","endTime":"0","summary":"11月16日，89Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.49亿美元，同比减少329.02%；其中营业收入为0.00美元，每股基本收益为-1.39美元。从资产负债表来看，89Bio, Inc.总负债80.20百万美元，其中短期债务743000.00美元，资产负债比为0.06，流动比率为0.12。机构评级：截至2024年11月16日，当前有7家机构对89Bio, Inc.目标价做出预测，其中目标均价为30.86美元，其中最低目标价为12.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000256a23b8989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000256a23b8989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.89bio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.905},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":0.0911},{"period":"3month","weight":0.0681},{"period":"6month","weight":0.0993},{"period":"1year","weight":0.3054},{"period":"ytd","weight":0.0817}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"89bio, Inc.于2019年6月作为一家特拉华州公司成立，以经营2018年1月在以色列注册成立的89Bio有限公司的业务。该公司是一家临床阶段的生物制药公司，专注于治疗肝脏和心脏代谢疾病的创新疗法的开发和商业化。公司主导候选产品pegozafermin是一种专门设计的成纤维细胞生长因子的糖聚乙二醇化类似物，目前正在开发用于治疗非酒精性脂肪性肝炎和用于治疗严重的高甘油三酯血症。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.111427},{"month":2,"riseRate":0.666667,"avgChangeRate":0.102838},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098837},{"month":4,"riseRate":0.5,"avgChangeRate":-0.083264},{"month":5,"riseRate":0.666667,"avgChangeRate":0.08296},{"month":6,"riseRate":0.5,"avgChangeRate":-0.019291},{"month":7,"riseRate":0.5,"avgChangeRate":0.06852},{"month":8,"riseRate":0.833333,"avgChangeRate":0.129221},{"month":9,"riseRate":0.5,"avgChangeRate":0.05512},{"month":10,"riseRate":0.5,"avgChangeRate":-0.001577},{"month":11,"riseRate":0.6,"avgChangeRate":-0.000698},{"month":12,"riseRate":0.333333,"avgChangeRate":0.097135}],"exchange":"NASDAQ","name":"89Bio, Inc.","nameEN":"89Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"89Bio, Inc.,ETNB,89Bio, Inc.股票,89Bio, Inc.股票老虎,89Bio, Inc.股票老虎国际,89Bio, Inc.行情,89Bio, Inc.股票行情,89Bio, Inc.股价,89Bio, Inc.股市,89Bio, Inc.股票价格,89Bio, Inc.股票交易,89Bio, Inc.股票购买,89Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}